Pervasive Developmental Disorder NOS Completed Phase 3 Trials for Risperidone (DB00734)

Also known as: Pervasive Developmental Disorder / Pervasive Developmental Disorders / Autistic continuum / Pervasive Development Disorders / Atypical autism / Autism spectrum disorder

IndicationStatusPhase
DBCOND0046531 (Pervasive Developmental Disorder NOS)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00399698Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone.Diagnostic